Revelation Biosciences's market cap is currently ―. The company's EPS TTM is $30.598; its P/E ratio is 0.07; Revelation Biosciences is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-5.38. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -2.63M	$ -1.45M	$ 6.16M	$ -1.21M	$ -1.20M
EBITDA	$ -2.62M	$ -1.44M	$ 6.17M	$ -1.20M	$ -1.19M
Net Income Common Stockholders	$ -2.63M	$ -1.45M	$ 6.16M	$ -1.21M	$ -1.17M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 13.99M	$ 15.71M	$ 17.70M	$ 5.25M	$ 6.20M
Total Assets	$ 14.22M	$ 16.04M	$ 18.12M	$ 5.50M	$ 6.60M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -13.99M	$ -15.71M	$ -17.70M	$ -5.25M	$ -6.20M
Total Liabilities	$ 5.40M	$ 4.62M	$ 8.10M	$ 4.45M	$ 4.37M
Stockholders Equity	$ 8.82M	$ 11.41M	$ 10.02M	$ 1.05M	$ 2.23M
Cash Flow	-
Free Cash Flow	$ -1.72M	$ -1.99M	$ -1.58M	$ -947.47K	$ -1.73M
Operating Cash Flow	$ -1.72M	$ -1.99M	$ -1.58M	$ -947.47K	$ -1.73M
Investing Cash Flow	-	-	-	-	$ 0.00
Financing Cash Flow	-	$ 15.00	$ 14.02M	$ 5.00K	$ 4.45M

Currency in USD

Revelation Biosciences Earnings and Revenue History

Income Statement >

Revelation Biosciences Debt to Assets

Balance Sheet >

Revelation Biosciences Cash Flow

Cash Flow >

Revelation Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing